Yahoo
Morningstar

Morningstar

•

Oct 21, 2026

Cencora, Inc.: Cencora: Doubles Down on Oncology With AON Acquisition; Fair Value Estimate Maintained

Symbols

COR

Sector(s)

Healthcare

Rating

Current Price

330.84

Fair Value

Economic Moat

Stewardship

Summary

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: